AMGEN INC — Director's Dealing 2019

Feb 15, 2019

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: AMGEN INC (AMGN)
CIK: 0000318154
Period of Report: 2018-12-31

Reporting Person: Santos Esteban (EVP, Operations)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	34167	Direct
Common Stock	727.7449	Indirect

Footnotes

F1: Due to administrative error, 533 shares of Company common stock were incorrectly included in the amount of securities beneficially owned on the reporting person's Form 3 filed with the Securities and Exchange Commission (SEC) on August 4, 2016. The holdings reflected in this table are the reporting person's current total holdings without the erroneous 533 shares.

F2: These shares include the following RSUs granted under the Company's equity plans: 686 RSUs which vest in one installment of 338 on 5/3/2019 and one installment of 348 on 5/3/2020; 7,694 RSUs which vest in one installment of 3,789 on 8/1/2019 and one installment of 3,905 on 8/1/2020; 3,444 RSUs which vest in installments of 1,136 on 5/1/2019, 1,137 on 5/1/2020 and 1,171 on 5/1/2021; and 3,155 RSUs which vest in two equal installments of 1,041 on 4/27/2020 and 4/27/2021 and 1,073 on 4/27/2022. These shares also include RSUs which vested on January 30, 2019, as reported on a Form 4 filed by the reporting person with the SEC on February 1, 2019. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.

F3: These shares include 820 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

F4: These shares are acquired under the Company's 401(k) Plan and represent interests in the Company's stock fund as of this filing.